Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Fusafungine-containing medicinal products - Important Safety Information from Servier Laboratories (Ireland) Ltd. as approved by the HPRA
Notice type:
3rd Party Publications
Date:
26/04/2016
Problem Or Issue:
Important Safety Information communication from Servier Laboratories (Ireland) Ltd.: Fusafungine-containing medicinal products for oromucosal and nasal use will no longer be available on the market.
Important Safety Information - Fusafungine-containing medicinal products
« Back
Date Printed: 20/04/2024